Clinical trial
A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of…
NCT00300924 · Diamond Headache Clinic, Other · Completed
Key facts
| NCT number | NCT00300924 |
|---|---|
| Title | A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine |
| Official title | A Double-Blind, Double-Dummy, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10mg Co-Administered With Acetaminophen for the Treatment of Acute Migraine. |
| Lead sponsor | Diamond Headache Clinic, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Drug |
| Interventions | Rizatriptan co-administered with Acetaminophen |
| Enrollment | 200 |
| Start date | Mar 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Mar 10, 2006 |
| Last update posted | May 28, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: